Results 181 to 190 of about 85,869 (275)

PRMT5 Methylates and Stabilizes EphA2 via Inhibiting Its Ubiquitination and Degradation to Promote Nasopharyngeal Carcinoma Stem Cell Properties

MedComm, Volume 7, Issue 4, April 2026.
PRMT5 binds and methylates EphA2, which stabilizes EphA2 via inhibiting Cbl‐mediated EphA2 ubiquitination degradation to promote NPC stemness. PRMT5‐derived peptide P20 disrupts PRMT5–EphA2 interaction, which degrades EphA2 via enhancing Cbl‐mediated EphA2 ubiquitination degradation to suppress NPC stemness.
Zheng‐Zheng Yu, Xue‐Li Mao, Shan‐Shan Lu, Ruo‐Huang Lu, Wei Zhu, Di Wu, Hong Yi, Wei Huang, Qi Wen, Guo‐Xiang Lin, Ting Zeng, Yun‐Xi Peng, Li Yuan, Ting Ran, Juan Feng, Jinwu Peng, Zhi‐Qiang Xiao   +16 more
wiley   +1 more source

Therapeutic efficacy of genetically engineered neural stem cells in cerebral ischemia: a systematic review and meta-analysis. [PDF]

J Transl Med
Li S, Solis Marzan RA, Wei C, Razak A, Wong CHY, Moore J, McDonald CA.   +6 more
europepmc   +1 more source

Uncoupling TGFβ1 signalling from collagen protein synthesis in Dupuytren's disease

The Journal of Pathology, Volume 268, Issue 4, Page 383-397, April 2026.
Abstract Dupuytren's disease is a fibroproliferative disorder of the palmer fascia (PF) characterised by flexion contractures in the hand. Dupuytren's disease can be treated surgically, but disease recurrence rates are high, potentially due to continual production of matrisomal proteins.
Gabriella Cooper, Jade A Gumbs, Sahem Alkharabsheh, Katie J Lee, Alan Carter, Hannah Coleman, Niamh S O'Heneghan‐Yates, Rama Ijaz, Emma Beamish, Lisa A Menezes, Triantafillos Liloglou, Peter D Clegg, Elizabeth G. Canty‐Laird   +12 more
wiley   +1 more source

Dehydroascorbic Acid Induces Cell Death in Sarcoma Stem Cells Under bFGF-Mediated Stemness-Supporting Conditions. [PDF]

Antioxidants (Basel)
Ledinski M, Caput Mihalić K, Šimić Jovičić M, Ostojić K, Škibola Z, Kolundžić R, Urlić I.   +6 more
europepmc   +1 more source

Research Progress on Platelet‐Rich Plasma (PRP) in the Treatment of Androgenetic Alopecia

Journal of Cosmetic Dermatology, Volume 25, Issue 4, April 2026.
ABSTRACT Background Androgenetic alopecia (AGA) is the most common cause of progressive hair loss, significantly affecting quality of life. Current therapies, such as minoxidil, finasteride, and hair transplantation, show variable efficacy and may be associated with adverse effects.
Zetian Zhong, Li Luo, Lixiang Zhao, Xupeng Yue, Yanxin Lu   +4 more
wiley   +1 more source

Basic Fibroblast Growth Factor, bFGF

The Journal of Japan Atherosclerosis Society, 1996
openaire   +2 more sources

Immunophenotypic characterization of canine oligodendroglioma cells cultured in an oligodendrocyte precursor cell-tailored medium. [PDF]

J Vet Med Sci
Yoshida K, Chambers JK, Kakishima K, Uchida K.   +3 more
europepmc   +1 more source

Targeting Arterial Dysfunction in Cardiovascular Disease Using Stem Cell‐Based Therapies

The FASEB Journal, Volume 40, Issue 6, 31 March 2026.
Graphical presentation of stem cell‐based therapies for arterial dysfunction, endothelial repair and regeneration strategies. SMC, smooth muscle cell. ABSTRACT Arterial regeneration represents a critical frontier in cardiovascular medicine, as progressive endothelial dysfunction, maladaptive vascular smooth muscle cell (SMC) plasticity, and chronic ...
Yun‐Yu Ma, Shu‐Yao Zhu, Yi Song
wiley   +1 more source

pH-responsive bilayer hydrogel with sequential release of morin-based nanoparticles and bFGF for the treatment of the "ice and fire" wounds. [PDF]

Mater Today Bio
Yi M, Jin W, Li H, Niu X, Wang J, Wang S, Zhang W, Zhou M, Wang Z, Zhou Y, Deng X, Huang J, Su X.   +12 more
europepmc   +1 more source

Basic Fibroblast Growth Factor-Releasing Bioabsorbable Polyglycolic Acid Dura Mater Enhances Neural Progenitor Cell Proliferation and Neuroprotection After Brain Injury. [PDF]

Brain Behav
Ito Y, Oyane A, Matsumaru Y, Ishikawa E.
europepmc   +1 more source